Showing results (11-20 of 389) with videos related to
Sort By:
Pageof 39
Cancer Immunology, Immunotherapy : CII|January 20, 2004
MHC class II and CD80 tumor cell-based vaccines are potent activators of type 1 CD4+ T lymphocytes provided they do not coexpress invariant chainDan Ilkovitch, Suzanne Ostrand-RosenbergCancer Immunology, Immunotherapy : CII|August 29, 2013
Myeloid-derived suppressor cell function is reduced by Withaferin A, a potent and abundant component of Withania somnifera root extractPratima Sinha, Suzanne Ostrand-RosenbergJournal of Immunology (Baltimore, Md. : 1950)|January 10, 2018
Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their EnvironmentSuzanne Ostrand-Rosenberg, Catherine FenselauCellular Immunology|December 18, 2020
Molecular cargo in myeloid-derived suppressor cells and their exosomesCatherine Fenselau, Suzanne Ostrand-RosenbergCancers|February 25, 2023
The Receptor for Advanced Glycation Endproducts (RAGE) and Its Ligands S100A8/A9 and High Mobility Group Box Protein 1 (HMGB1) Are Key Regulators of Myeloid-Derived Suppressor CellsSuzanne Ostrand-Rosenberg, Tom Huecksteadt, Karl SandersJournal of Immunology (Baltimore, Md. : 1950)|February 9, 2005
Presentation of endogenously synthesized MHC class II-restricted epitopes by MHC class II cancer vaccines is independent of transporter associated with Ag processing and the proteasomeSamudra K Dissanayake, Natalia Tuera, Suzanne Ostrand-RosenbergJournal of Immunology (Baltimore, Md. : 1950)|January 7, 2005
Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic diseasePratima Sinha, Virginia K Clements, Suzanne Ostrand-RosenbergCancer Research|December 17, 2005
Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasisPratima Sinha, Virginia K Clements, Suzanne Ostrand-RosenbergNature Reviews. Immunology|March 23, 2012
Coordinated regulation of myeloid cells by tumoursDmitry I Gabrilovich, Suzanne Ostrand-Rosenberg, Vincenzo BronteAdvances in Cancer Research|July 29, 2015
Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor MicroenvironmentKatherine H Parker, Daniel W Beury, Suzanne Ostrand-RosenbergPageof 39